{"url_path":"/sec/drio/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1533998/0001104659-26-059676-index.html","accession_number":"0001104659-26-059676","cik":"0001533998","ticker":"DRIO","issuer_name":"DarioHealth Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1533998/0001104659-26-059676-index.html","primary_entity_key":"0001533998","primary_entity_name":"DarioHealth Corp."},"word_count":266,"has_tables":true,"body_markdown":"Item 6. Exhibits.\n\n**No.**\n\n  ​ ​ ​\n\n**Description of**\n**Exhibit** \n\n10.1\n\n​\n\n[Sales Agreement between the Company and A.G.P./Alliance Global Partners, dated March 30, 2026 (incorporated by reference to Exhibit 10.1 filed with the Company’s Current Report on Form 8-K filed on March 30, 2026).](https://www.sec.gov/Archives/edgar/data/1533998/000110465926036834/tm2610107d1_ex10-1.htm)\n\n31.1*\n\n​\n\n[Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a).](drio-20260331xex31d1.htm)\n\n31.2*\n\n​\n\n[Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a).](drio-20260331xex31d2.htm)\n\n32.1**\n\n​\n\n[Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350.](drio-20260331xex32d1.htm)\n\n32.2**\n\n​\n\n[Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350.](drio-20260331xex32d2.htm)\n\n101.1*\n\n​\n\nThe following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, formatted in Inline XBRL: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Comprehensive Loss, (iii) Statements of Changes in Stockholders’ Equity, (iv) Consolidated Statements of Cash Flows and (v) the Notes to Consolidated Financial Statements, tagged as blocks of text and in detail.\n\n104\n\n​\n\nCover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101).\n\n​\n\n​\n\n​\n\n*Filed herewith.\n\n**Furnished herewith.\n\n​\n\n​\n\n13\n\n[Table of Contents](#TOC)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDate: May 13, 2026\n\n**DarioHealth Corp.**\n\nBy:\n\n/s/ Erez Raphael\n\nName:\n\nErez Raphael\n\nTitle:\n\nChief Executive Officer (Principal Executive Officer)\n\nBy:\n\n/s/ Chen Franco-Yehuda\n\nName:\n\nChen Franco-Yehuda\n\nTitle:\n\nChief Financial Officer, Secretary and Treasurer (Principal Financial Officer)\n\n​\n\n14"}